cyclin-dependent kinase 4 and 6 inhibitors and is also classified generally as an antineoplastic agent
Generic Name:
Palbociclib
Indication:
For:
Palbociclib is an endocrine-based chemotherapeutic agent used in combination with other antineoplastic agents to treat HER2-negative and HR-positive advanced or metastatic breast cancer.
Supplied as:
Tablet:
125mg
Disclaimer:
Please consult your doctor before taking any medicine. To be sold only on prescription.